← Leaderboards
Papireddy Kancharla
Portland State University
$1,470,310
Attributed
$3,801,381
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,801,381 · 2
By mechanism
R01$3,801,381 · 2
Top collaborators
- Jane X Kelly6 shared
- Alison Roth4 shared
Most similar at Portland State University
Same institution · by research overlap
- Alison Elizabeth Roth$2,503,100
- Alison Roth$860,762
- Victor Melendez$1,058,418
- Lisa Read$353,819
- Mara Kreishman-Deitrick$357,550
Others in their field
Other Rising Stars on “Oral”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Suma Babu · Massachusetts General Hospital$15,344,018
- Sabrina Paganoni · Massachusetts General Hospital$15,344,018
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Eric Anderson · Columbia University Health Sciences$11,474,975
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
Research focus
OralPermeabilityNonhuman PrimateLiverParasitesLead CandidateIn VitroMalariaIn VivoIsoenzymesMetabolic ProfileMetabolicChemical SynthesisChildDrug InteractionsDrug ResistanceInfectionIterative DesignBioluminescence ImagingDrug KineticsBloodCytochrome P450Malaria InfectionPharmaceutical Preparations
Grant awards (6)
Novel Multiple-Stage Active Antimalarials$681,816
R01 · FY2025 · AI · contact PI
Natural Product Inspired Novel Antimalarials with Radical Cure Potential$618,729
R01 · FY2025 · AI · contact PI
Natural Product Inspired Novel Antimalarials with Radical Cure Potential$625,296
R01 · FY2024 · AI · contact PI
Natural Product Inspired Novel Antimalarials with Radical Cure Potential$656,445
R01 · FY2023 · AI · contact PI
Novel Multiple-Stage Active Antimalarials$602,825
R01 · FY2023 · AI
Novel Multiple-Stage Active Antimalarials$616,270
R01 · FY2022 · AI